4
Changes in Ownership
Edwards Lifesciences Corp Filed Acc 0001225208-24-010858
CVP, JAPAC sold 2,500 shares at $74.08 ($185,196)
- CVP, JAPAC acquired 2,500 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Lippis Daniel J. · CVP, JAPAC
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-12-16 | Exercise or conversion : show line 1 in the form 10b5-1 | +2,500 | $45.28 | $113,192 | 25,689.07 | D |
| 2024-12-16 | Sale : show line 2 in the form 10b5-1 | −2,500 | $74.08 | $185,196 | 23,189.07 | D |
| Open-market sales · 2,500 sh · avg $74.08 · $185,196 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-12-16 | Exercise or conversion : show line 3 in the form 10b5-1 Employee Stock Option (Right to Acquire) | −2,500 | 2,030 | D |
Loading xslF345X05/doc4.xml…